Rankings
▼
Calendar
CTKB
Cytek Biosciences, Inc.
$523M
FY 2019 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$58M
Gross Profit
$29M
49.5% margin
Operating Income
-$17M
-29.8% margin
Net Income
-$17M
-29.1% margin
EPS (Diluted)
$-0.13
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$15M
Stock-Based Comp.
$269,000
Balance Sheet
Total Assets
$70M
Total Liabilities
$112M
Stockholders' Equity
-$42M
Cash & Equivalents
$30M
← Q1 2020
All Quarters
CTKB FY 2019 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena